Literature DB >> 18259089

Cerebrospinal fluid amino acids in pathological gamblers and healthy controls.

Conny Nordin1, Ramesh C Gupta, Ingemar Sjödin.   

Abstract

Amino acids, such as valine, isoleucine and leucine compete with tyrosine and tryptophan for transport into the brain and might thus affect the central serotonin and catecholamine patterns. Furthermore, the excitatory amino acids glutamic acid, aspartic acid and glycine are known to act on the N-methyl-D-aspartate receptor, which is part of the reward system. Based on these facts, we have explored the role of cerebrospinal fluid (CSF) amino acids in pathological gambling. Concentrations of amino acids were determined in CSF obtained from one female and 11 pathological male gamblers and 11 healthy male controls. In an ANCOVA with best subset regression, pathological male gamblers had higher CSF levels of the excitatory glutamic and aspartic acids, as well as of phenylalanine, isoleucine, citrulline and glycine. A negative contribution of glycine in interaction with the neuraxis distance might mirror a reduced spinal supply or an altered elimination of glycine in pathological gamblers. A decreasing CSF gradient from the first (0-6 ml) to the third (13-18 ml) CSF fraction was found for glutamic acid, glycine, leucine, isoleucine, lysine, ornithine and glutamine in both pathological gamblers and healthy controls. A decreasing gradient was found, however, for aspartic acid and phenylalanine in pathological male gamblers. The altered pattern of CSF amino acids in pathological gamblers might exert an influence on central monoamines as well as on N-methyl-D-aspartate receptor function. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259089     DOI: 10.1159/000115782

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  7 in total

1.  Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects.

Authors:  Emil F Coccaro; Royce Lee; Paul Vezina
Journal:  J Psychiatr Res       Date:  2013-06-18       Impact factor: 4.791

Review 2.  The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.

Authors:  Gabriele Sani; Giulia Serra; Giorgio D Kotzalidis; Silvia Romano; Stefano M Tamorri; Giovanni Manfredi; Matteo Caloro; C Ludovica Telesforo; Saverio S Caltagirone; Isabella Panaccione; Alessio Simonetti; Francesca Demontis; Gino Serra; Paolo Girardi
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

3.  Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiation.

Authors:  Judith Buddensiek; Alexander Dressel; Michael Kowalski; Uwe Runge; Henry Schroeder; Andreas Hermann; Matthias Kirsch; Alexander Storch; Michael Sabolek
Journal:  BMC Neurosci       Date:  2010-04-08       Impact factor: 3.288

4.  Pathological Gambling: Neuropsychopharmacology and Treatment.

Authors:  Scott A Bullock; Marc N Potenza
Journal:  Curr Psychopharmacol       Date:  2012-02-01

5.  Neural differentiation of choroid plexus epithelial cells: role of human traumatic cerebrospinal fluid.

Authors:  Elham Hashemi; Yousef Sadeghi; Abbas Aliaghaei; Afsoun Seddighi; Abbas Piryaei; Mehdi Eskandarian Broujeni; Fatemeh Shaerzadeh; Abdollah Amini; Ramin Pouriran
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

6.  Neural differentiation of human umbilical cord mesenchymal stem cells by cerebrospinal fluid.

Authors:  Shirin Farivar; Zahra Mohamadzade; Reza Shiari; Alireza Fahimzad
Journal:  Iran J Child Neurol       Date:  2015

Review 7.  Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.

Authors:  Mauro Pettorruso; Luisa De Risio; Giovanni Martinotti; Marco Di Nicola; Filippo Ruggeri; Gianluigi Conte; Massimo Di Giannantonio; Luigi Janiri
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.